Error: Could not add to watchlist. X
+ Watchlist

Myrexis Inc

R9M:GR
Frankfurt
Price not available for R9M:GR
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding (m)
34.479
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Myrexis Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing novel small molecule drugs for the treatment of cancer. Myriad's pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures.
Address
305 Chipeta Way
Salt Lake City, UT 84108
United States
Phone
1-801-214-7800
Show More